Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Eloxx Pharmaceuticals, Inc. ELOX

Full chart Compare

Set alert

13.15 USD +0.26 (+2.02%)

At closeNov 13, 2026, 4:00 PM EST

13.25 +0.10 +0.76%

After hours · Nov 13, 4:00 PM ET

12.07 Day range 13.23

10.95 52-week range 20.98

YTD: +19.44%
1 year: +19.44%

News

2 weeks ago benzinga.com Guggenheim Maintains Buy on Eloxx Pharma, Lowers Price Target to $40 Guggenheim analyst Vamil Divan maintains Eloxx Pharma (NASDAQ:ELOX) with a Buy and lowers the price target from $43 to $40.
3 weeks ago benzinga.com Eloxx Pharmaceuticals Finalizes Design For Its EXPRESS Phase 2 Global Trial In Nonsense-Mutation Autosomal Dominant Polycystic Kidney Disease To Enrolol 60 Adults With Genetically Confirmed PKD1 Or PKD2 Nonsense Mutations Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), a clinical-stage biopharmaceutical company developing exaluren for the treatment of rare kidney diseases, today announced the finalized design of its…
4 weeks ago benzinga.com This Eloxx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday Analysts initiated coverage: Neutral on RDW, Overweight on ELOX, Buys on SGHT and AU, and Market Perform on FFIN.
4 weeks ago benzinga.com Cantor Fitzgerald Initiates Coverage On Eloxx Pharma with Overweight Rating Cantor Fitzgerald analyst Yanni Souroutzidis initiates coverage on Eloxx Pharma (NASDAQ:ELOX) with a Overweight rating.